全球基因编辑市场规模、份额和成长分析：按技术、按产品、按应用、按最终用户、按地区 - 行业预测 (2024-2031)

2022年全球基因编辑市场规模为54亿美元，从2023年的62.4亿美元成长到2031年的197.5亿美元，预计在预测期间（2024-2031年）将以复合年增长率成长。

由于生物技术的进步，特别是透过 CRISPR-Cas9 和 TALEN 等技术，全球基因编辑市场正在经历显着成长。对个人化医疗的需求和不断增加的研发投资以及遗传疾病和癌症治疗应用的扩大是该市场的主要驱动力。基因编辑也被应用于农业，以提高作物产量和抗病能力。面对激烈的竞争，包括製药和生物技术公司在内的领先公司正在组成战略联盟，以扩大其研究能力。北美在先进的医疗保健系统的支持下引领市场，而亚太地区则在医疗保健支出增加和政府支持的推动下实现强劲增长。儘管存在道德和监管方面的挑战，但该市场预计在未来几年将大幅成长。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析和影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 案例研究

基因编辑市场规模：依技术划分，复合年增长率（2024-2031）

• 市场概况
• CRISPR
• TALENs
• 锌指核酸酶 (ZFN)
• 限制性内切酶
• 其他的

基因编辑市场规模：依产品划分，复合年增长率（2024-2031）

• 市场概况
• 产品
  • 套件
  • 试剂
  • 图书馆
  • 软体
• 服务
  • gRNA合成
  • 向量建构
  • 细胞株工程

基因编辑市场规模：依应用划分，复合年增长率（2024-2031）

• 市场概况
• 基因工程
  • 动物基因工程
  • 植物基因工程
• 临床应用
  • 基因治疗
  • 细胞疗法
  • 诊断
• 药物发现与开发
• 农业

基因编辑市场规模：依最终用户划分，复合年增长率（2024-2031）

• 市场概况
• 製药和生物技术公司
• 学术研究所
• 合约研究组织（CRO）
• 其他的

基因编辑市场规模，复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• CRISPR Therapeutics
• Editas Medicine
• Intellia Therapeutics
• Sangamo Therapeutics
• Precision BioSciences
• Beam Therapeutics
• Cellectis
• Horizon Discovery Group
• Bluebird Bio
• Caribou Biosciences
• Synthego Corporation
• Origene Technologies
• Genscript Biotech Corporation
• Lonza Group
• Merck KGaA
• Thermo Fisher Scientific
• Agilent Technologies
• Takara Bio Inc.
• New England Biolabs
• Inscripta, Inc.

结论和建议

Global Gene Editing Market size was valued at USD 5.40 billion in 2022 and is poised to grow from USD 6.24 billion in 2023 to USD 19.75 billion by 2031, growing at a CAGR of 15.5% during the forecast period (2024-2031).

The Global Gene Editing Market has seen remarkable growth due to advancements in biotechnology, particularly through technologies like CRISPR-Cas9 and TALENs. The demand for personalized medicine and increased investments in R&D are key drivers of this market, alongside the expanding therapeutic applications for genetic disorders and cancers. The agriculture sector is also embracing gene editing to enhance crop yield and resistance to diseases. Major players, including pharmaceutical and biotechnology companies, are engaged in strategic collaborations to broaden their research capabilities amid intense competition. North America leads the market, backed by advanced healthcare systems, while Asia-Pacific is poised for significant growth fueled by rising healthcare spending and governmental support. Despite ethical and regulatory challenges, the market is expected to grow substantially in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Editing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Editing Market Segmental Analysis

Global Gene Editing Market is segmented by technology, offerings, application, end user and region. Based on technology, the market is segmented into CRISPR, TALENs, zinc finger nucleases (ZFNs), restriction enzymes and others. Based on offerings, the market is segmented into products and services. Based on application, the market is segmented into genetic engineering, clinical applications, drug discovery and development and agriculture. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs) and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gene Editing Market

A major factor propelling the global gene editing market is the rising demand for personalized medicine. Gene editing technologies provide opportunities to craft bespoke therapies and treatments, specifically designed around an individual's unique genetic profile. This customized approach not only promises better treatment effectiveness and fewer side effects but also aims to enhance overall patient health. As awareness of personalized medicine grows, so too does the push for targeted therapies, significantly driving the adoption and progression of gene editing innovations. Consequently, the drive for personalized healthcare solutions is a crucial catalyst in the evolution of the gene editing landscape.

Restraints in the Global Gene Editing Market

A significant restraint in the global gene editing market stems from ethical and regulatory challenges inherent to the technology. The manipulation of genetic material raises intricate ethical dilemmas, especially concerning germline editing and changes that can be passed to future generations. Ongoing debates surrounding the moral implications and potential long-term effects of gene editing further complicate its acceptance. Moreover, the regulatory landscapes governing gene editing practices differ widely across jurisdictions and are in a constant state of flux. The imperative for robust ethical guidelines and unambiguous regulatory frameworks presents a notable obstacle to the market's expansion and broader implementation.

Market Trends of the Global Gene Editing Market

The global gene editing market is increasingly centered on therapeutic applications, significantly driving growth in gene therapies. As advancements in technologies such as CRISPR and TALEN enable precise interventions at the genetic level, there is a heightened focus on addressing genetic disorders, cancers, and other complex diseases through targeted treatments. This shift is catalyzed by a surge in research initiatives and collaborations among biopharmaceutical companies, academic institutions, and healthcare organizations, aimed at unlocking the full potential of gene editing for innovative therapies. The burgeoning interest in personalized medicine underscores the transformative impact of gene editing on the future of healthcare, particularly in meeting unmet medical needs.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Gene Editing Market Size by Technology & CAGR (2024-2031)

• Market Overview
• CRISPR
• TALENs
• Zinc Finger Nucleases (ZFNs)
• Restriction Enzymes
• Others

Global Gene Editing Market Size by Offerings & CAGR (2024-2031)

• Market Overview
• Products
  • Kits
  • Reagents
  • Libraries
  • Software
• Services
  • gRNA Synthesis
  • Vector Construction
  • Cell Line Engineering

Global Gene Editing Market Size by Application & CAGR (2024-2031)

• Market Overview
• Genetic Engineering
  • Animal Genetic Engineering
  • Plant Genetic Engineering
• Clinical Applications
  • Gene Therapy
  • Cell Therapy
  • Diagnostics
• Drug Discovery and Development
• Agriculture

Global Gene Editing Market Size by End User & CAGR (2024-2031)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Contract Research Organizations (CROs)
• Others

Global Gene Editing Market Size & CAGR (2024-2031)

• North America, (Technology, Offerings, Application, End User)
  • US
  • Canada
• Europe, (Technology, Offerings, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Technology, Offerings, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Technology, Offerings, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Technology, Offerings, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• CRISPR Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangamo Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision BioSciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beam Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bluebird Bio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caribou Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthego Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Origene Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genscript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inscripta, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation